Practical issues of oral iron administration for anemia in patients with cardiovascular diseases


DOI: https://dx.doi.org/10.18565/therapy.2021.10.178-187

Posnenkova O.M., Kaluta T.Yu.

V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia
Abstract. The article reviews the data on oral iron administration in patients with cardiovascular diseases accompanied by iron deficiency anemia. We analyzed studies from eLibrary, PubMed, Google Scholar and clinicaltrials.gov databases since 2015 till 2020 as well as Russian and international clinical guidelines. On the basis of this information we provide practical advice for doctors on when and how administer oral iron to patients with cardiovascular diseases and low level of hemoglobin in a real clinical practice.
Keywords: oral iron, iron deficiency anemia, cardiovascular diseases
Read entire article

Literature


  1. Gardner W., Kassebaum N. Global, regional, and national prevalence of anemia and its causes in 204 countries and territories, 1990–2019. Curr Dev Nutr. 2020; 4(Suppl 2): 830. doi: 10.1093/cdn/nzaa053_035.

  2. Harper J.L., Besa E.C. What is the prognosis of chronic iron deficiency anemia? Medscape. Updated: Sep 30, 2020. Available at: https://www.medscape.com/answers/202333-153114/what-is-the-prognosis-of-chronic-iron-deficiency-anemia (date of access – 01.12.2021).

  3. Roth A.G., Mensah A.G., Johnson C.O. et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020; 76(25): 2982–3021. doi: 10.1016/j.jacc.2020.11.010.

  4. Cohen-Solal A., Leclercq C., Deray G. et al. Iron deficiency: an emerging therapeutic target in heart failure. Heart. 2014; 100(18): 1414–20. doi: 10.1136/heartjnl-2014-305669.

  5. Anand I.S., Gupta P. Anemia and iron deficiency in heart failure. Current concepts and emerging therapies. Circulation. 2018; 138(1): 80–98. doi: 10.1161/CIRCULATIONAHA.118.030099.

  6. Von Haehling S., Ebner N., Evertz R. et al. Iron deficiency in heart failure. An overview. JACC Heart Fail. 2019; 7(1): 36–46. doi: 10.1016/j.jchf.2018.07.015.

  7. Aronson D., Suleiman M., Agmon Y. et al. Changes in haemoglobin levels during hospital course and longterm outcome after acute myocardial infarction. Eur Heart J. 2007; 28(11): 1289–96. doi: 10.1093/eurheartj/ehm013.

  8. Hasin T., Sorkin A., Markiewicz W. et al. Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction. Am J Cardiol. 2009; 104(4): 486–91. doi: 10.1016/j.amjcard.2009.03.066.

  9. Padda J., Khalid K., Hitawala G. et al. Acute anemia and myocardial infarction. Cureus. 2021; 13(8): e17096. Doi: 10.7759/cureus.17096.

  10. Регистр АГ, ИБС и ХСН. Доступ: http://62.117.81.44/Register/ (дата обращения – 01.12.2021). [Register of hypertension, ischemic heart disease and heart failure. Available at: http://62.117.81.44/Register/ (date of access – 01.12.2021) (In Russ.)].

  11. Федеральный регистр больных с острым коронарным синдромом. Доступ: https://federalregistry.ru (дата обращения – 01.12.2021). [Federal register of patients with acute coronary syndrome. Available at: https://federalregistry.ru (date of access – 01.12.2021) (In Russ.)].

  12. Mamas M.A., Kwok C.S., Kontopantelis E. et al. Relationship between anemia and mortality outcomes in a National acute coronary syndrome cohort: Insights from the UK myocardial ischemia National audit project registry. J Am Heart Assoc. 2016; 5(11): e003348. doi: 10.1161/JAHA.116.003348.

  13. Huynh R., Hyun K., D’Souza M. et al. Outcomes of anemic patients presenting with acute coronary syndrome: An analysis of the Cooperative National Registry of acute coronary care, guideline adherence and clinical events. Clin Cardiol. 2019; 42(9): 791–96. doi: 10.1002/clc.23219.

  14. Qaseem A., Humphrey L.L., Fitterman N. et al. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013; 159(11): 770–79. doi: 10.7326/0003-4819-159-11-201312030-00009.

  15. Клинические рекомендации. Хроническая сердечная недостаточность. Ассоциация сердечно-сосудистых хирургов России, Ассоциация флебологов России, Ассоциация нейрохирургов России. 2020. ID: 156. Рубрикатор клинических рекомендаций Минздрава России. Доступ: https://cr.minzdrav.gov.ru/schema/156_1 (дата обращения – 01.12.2021). [Clinical guidelines. Chronic heart failure. Association of Cardiovascular Surgeons of Russia, Association of Phlebologists of Russia, Association of Neurosurgeons of Russia. 2020. ID: 156. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. Available at: https://cr.minzdrav.gov.ru/schema/156_1 (date of access – 01.12.2021) (In Russ.)].

  16. McDonagh T.A., Metra M., Adamo M. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–726. doi: 10.1093/eurheartj/ehab368.

  17. Yancy C.W., Jessup M., Bozkurt B. et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017; 136(6): e137–e161. doi: 10.1161/CIR.0000000000000509.

  18. Клинические рекомендации. Железодефицитная анемия. Национальное гематологическое общество, Национальное общество детских гематологов, онкологов. 2021. ID: 669. Рубрикатор клинических рекомендаций Минздрава России. Доступ: https://cr.minzdrav.gov.ru/schema/669_1 (дата обращения – 01.12.2021). [Clinical guidelines. Iron deficiency anemia. National Hematological Society, National Society of Pediatric Hematologists, Oncologists. 2021. ID: 669 Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. Available at: https://cr.minzdrav.gov.ru/schema/669_1 (date of access – 01.12.2021) (In Russ.)].

  19. Lewis G.D., Malhotra R., Hernandez A.F. et al., for the NHLBI heart failure clinical research network. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA. 2017; 317(19): 1958–66. doi: 10.1001/jama.2017.5427.

  20. Stout K.K., Daniels K.J., Aboulhosn J.A. et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease. JACC. 2019; 73(12): e81–e192. doi: 10.1016/j.jacc.2018.08.1029.

  21. Tay E.L.W., Peset A., Papaphylactou M. et al. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol. 2011; 151(3): 307–12. doi: 10.1016/j.ijcard.2010.05.066.

  22. Padmanabhan H., Siau K., Nevill A.M. et al. Intravenous iron does not effectively correct preoperative anaemia in cardiac surgery: a pilot randomized controlled trial. Interact Cardiovasc Thorac Surg. 2019; 28(3): 447–54. doi: 10.1093/icvts/ivy226.

  23. Kaundal R., Bhatia P., Jain A. et al. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol. 2020; 99(1): 57–63. doi: 10.1007/s00277-019-03871-z.

  24. Клинические рекомендации. Анемия при хронической болезни почек. Национальное общество детских гематологов, онкологов, Национальное гематологическое общество. 2020. ID: 623. Рубрикатор клинических рекомендаций Минздрава России. Доступ: https://cr.minzdrav.gov.ru/schema/623_4 (дата обращения – 01.12.2021). [Clinical guidelines. Anemia in chronic kidney disease. National Society of Pediatric Hematologists, Oncologists, National Hematological Society. 2020. ID: 623. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. Available at: https://cr.minzdrav.gov.ru/schema/623_4 (date of access – 01.12.2021) (In Russ.)].

  25. Клинические рекомендации. Анемия при злокачественных новообразованиях. Национальное гематологическое общество, Национальное общество детских гематологов, онкологов. 2020. ID: 624. Рубрикатор клинических рекомендаций Минздрава России. Доступ: https://cr.minzdrav.gov.ru/schema/624_1 (дата обращения – 01.12.2021). [Clinical guidelinesю Anemia in cancer. National Hematological Society, National Society of Pediatric Hematologists, Oncologists. 2020. ID: 624. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. Available at: https://cr.minzdrav.gov.ru/schema/624_1 (date of access – 01.12.2021) (In Russ.)].

  26. ГОСТ Р 52600.4-2008. Протокол ведения больных. Железодефицитная анемия. М.: Стандартинформ. 2009. Доступ: https://docs.cntd.ru/document/1200068753?section=status (дата обращения – 01.12.2021). [GOST R 52600.4-2008. Protocol for patient’s management. Iron deficiency anaemia. Moscow: Standartinform. 2009. Available at: https://docs.cntd.ru/document/1200068753?section=status (date of access – 01.12.2021) (In Russ.)].

  27. Khadadah F., Callum J., Shelton D., Lin Yu. Improving quality of care for patients with iron deficiency anemia presenting to the emergency Department. Transfusion. 2018; 58(8): 1902–08. doi: 10.1111/trf.14626.

  28. Brownlee T., Dersch-Mills D., Cummings G. et al. Patient factors associated with prescribing of iron for IV administration: A descriptive study. Can J Hosp Pharm. 2021; 74(1): 50–56.

  29. Бапаева М.К. Ферротерапия: изучение фармакоэкономических параметров у пациентов с железодефицитной анемией. Известия вузов (Кыргызстан). 2008; 5–6: 297–300. [Bapaeva M.K. Ferrothedrapy: studying pharmacoeconomic parameters in patients with iron deficiency anemia. Izvestija Vuzov (Kyrgyzstan) = Bulletin of Higher Educational Institutions (Kyrgyzstan). 2008; 5–6: 297–300 (In Russ.)].

  30. Федорук А.В., Воробьев П.А., Некрасова Н.И., Доркина А.А. Анализ врачебной практики ведения больных железодефицитной анемией в различных возрастных группах. Клиническая геронтология. 2005; 10: 8–14. [Fedoruk A.V., Vorobiev P.A., Nekrasova N.I., Dorkina A.A. Analysis of doctor’s practices in management of patients with iron deficiency anemia in different age groups. Klinicheskaya gerontologiya = Clinical Gerontology. 2005; 10: 8–14 (In Russ.)].

  31. Кабасова К.К. Применение препарата Сорбифер Дурулес при лечении железодефицитных анемий. Журнал Национального научного центра хирургии им. А.Н. Сызганова. 2012; 1: 135. [Kabasova K.K. Using Sorbifer Durules for treatment of iron deficiency anemias. Zhurnal Natsional’nogo nauchnogo tsentra khirurgii im. A.N. Syzganova = Journal of the National Scientific Center for Surgery named after A.N. Syzganov. 2012; 1: 135 (In Russ.)].

  32. Дворецкий Л.И., Заспа Е.А. Сравнительная эффективность железосодержащих препаратов у больных железодефицитной анемией. Клиницист. 2007; 1: 31–37. [Dvoretsky L.I., Zaspa Ye.A. Comparative efficacy of iron-containing preparations in patients with iron-deficiency anemia. Klinitsist = The Clinician. 2007; 1: 31–37 (In Russ.)].

  33. Инструкция по медицинскому применению препарата Сорбифер Дурулес. РУ: ЛП-N (000080)-(РГ-RU). Государственный реестр лекарственных средств Минздрава России. Доступ: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8ba0382b-86d4-4768-8891-9c3d3dba435f&t= (дата обращения – 01.12.2021). [Instructions for the medical use of Sorbifer Durules. Registration certificate: РУ: ЛП-N (000080)-(РГ-RU). State Register of Medicines of the Ministry of Healthcare of Russia. Available at: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8ba0382b-86d4-4768-8891-9c3d3dba435f&t= (date of access – 01.12.2021) (In Russ.)].

  34. Rybo G., Solvell L. Side-effect studies on a new sustained release iron preparation. Scand J Haematol. 1971; 8(4): 257–64. doi: 10.1111/j.1600-0609.1971.tb00873.x.


About the Autors

Olga M. Posnenkova, MD, head of the Department of atherosclerosis and chronic coronary artery disease of the Research Institute of Cardiology, V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia. Address: 410012, Saratov, 112 Bol’shaya Kazach’ya Str. Tel.: +7 (905) 380-39-07. E-mail: posnenkova@cardio-it.ru. ORCID: 0000-0001-5311-005X
Tatiana Yu. Kalyuta, PhD, senior researcher at the Department of preventive cardiology and rehabilitation of the Research Institute of Cardiology, V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia. Address: 410012, Saratov, 112 Bol’shaya Kazach’ya Str. Tel.: +7 (905) 386-71-23. E-mail: tatianakaluta@yandex.ru. ORCID: 0000-0003-3172-0804


Similar Articles

Back to Content

Бионика Медиа